Skip to main
AMN

AMN Stock Forecast & Price Target

AMN Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 20%
Buy 40%
Hold 40%
Sell 0%
Strong Sell 0%

Bulls say

AMN Healthcare Services is positioned for a constructive recovery as its core Nurse and Allied business shows the first return to volume growth since 2022, with Q1 excluding labor disruption and rapid response revenue up 5% sequentially and bill rates beginning to rise. The company also beat expectations with Q1 revenue of $1,378M and adjusted EBITDA of $166M, while margins expanded to 12.1% and net leverage improved to 1.6x, supported by $555M of Q1 cash flow and $561M of cash. Management’s outlook for stabilization in 2026 and a return to normalized mid-single-digit revenue growth and double-digit EBITDA growth by 2027, plus improving international nursing and language services margins, supports a favorable fundamental view.

Bears say

AMN Healthcare Services is facing weakening fundamentals as Physician and Leadership revenue fell 6% to $164M, locum tenens revenue dropped 7% Y/Y, and segment gross margin compressed 120 bps Y/Y to 26.1%, signaling soft demand and poorer mix. The larger Nurse and Allied business has also lost momentum, with organic revenue down 4% in 2025 and projected to decline another 4% in 2026, while days filled are expected to fall 9% and VMS revenue has already collapsed at a (35%) CAGR between 2022 and 2025. Heavy dependence on Kaiser Permanente, which represented 22% of consolidated revenue, combined with nearly $1B of debt and declining contract labor demand, increases downside risk to profitability and financial flexibility.

AMN has been analyzed by 5 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 40% recommend Buy, 40% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of AMN Healthcare Services and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About AMN Healthcare Services (AMN) Forecast

Analysts have given AMN a Buy based on their latest research and market trends.

According to 5 analysts, AMN has a Buy consensus rating as of Oct 24, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $36.80, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $36.80, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

AMN Healthcare Services (AMN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.